BiomimX_Brochure

BiomimX recently collaborated with a biotech company on an efficacy study for a novel therapeutic product targeting osteoarthritis. 

BiomimX Srl is now part of two prestigious consortia funded by the European Union's Horizon Europe Research and Innovation Program under the Marie Sklodowska-Curie Actions! These projects will extend the application of our uBeat®-based Organ-on-Chip (OoC) solutions into new, exciting areas

uBeat® technology essential in in vitro OoC to better mimic physio-pathologic human conditions.